SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3ozv'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ERR_B_RALB600_2 (ESTROGEN RECEPTOR)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	4 / 6	ASP B 264 MET B 284 LEU B 271 HIS B 392	None	1.22A	1errB-3ozvB: undetectable	1errB-3ozvB: 19.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1N2X_B_SAMB402_0 (S-ADENOSYL-METHYLTRA NSFERASE MRAW)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	5 / 12	GLY B 369 GLY B 274 GLY B 275 GLY B 397 ASN B 80	None None None FAD B 405 ( 4.4A) None	0.81A	1n2xB-3ozvB: 6.8	1n2xB-3ozvB: 22.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FXE_A_DR7A102_1 (POL PROTEIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	6 / 12	ALA B 309 GLY B 274 GLY B 277 PHE B 373 VAL B 223 ILE B 169	None None None None FAD B 405 (-3.9A) None	1.24A	2fxeA-3ozvB: undetectable	2fxeA-3ozvB: 13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QEU_A_ACTA141_0 (PUTATIVE CARBOXYMUCONOLACTONE DECARBOXYLASE)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	3 / 3	VAL B 263 ASP B 264 GLU B 186	None	0.61A	2qeuA-3ozvB: 2.5	2qeuA-3ozvB: 17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QEU_C_ACTC141_0 (PUTATIVE CARBOXYMUCONOLACTONE DECARBOXYLASE)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	3 / 3	VAL B 263 ASP B 264 GLU B 186	None	0.60A	2qeuC-3ozvB: 2.2	2qeuC-3ozvB: 17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QR2_B_VK3B236_1 (PROTEIN (QUINONE REDUCTASE TYPE 2))	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	4 / 5	TRP B 151 GLY B 180 GLY B 179 PHE B 157	None	1.04A	2qr2A-3ozvB: undetectable 2qr2B-3ozvB: 3.1	2qr2A-3ozvB: 22.36 2qr2B-3ozvB: 22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QXS_A_RALA600_2 (ESTROGEN RECEPTOR)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	4 / 5	ASP B 264 MET B 284 LEU B 271 HIS B 392	None	1.26A	2qxsA-3ozvB: undetectable	2qxsA-3ozvB: 19.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QXS_B_RALB600_2 (ESTROGEN RECEPTOR)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	4 / 5	ASP B 264 MET B 284 LEU B 271 HIS B 392	None	1.27A	2qxsB-3ozvB: undetectable	2qxsB-3ozvB: 19.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W98_A_P1ZA1351_1 (PROSTAGLANDIN REDUCTASE 2)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	5 / 10	TYR B 64 ILE B 68 LEU B 129 VAL B 132 LEU B 78	DGG B 406 ( 4.5A) None HEM B 404 ( 4.3A) None None	1.34A	2w98A-3ozvB: undetectable	2w98A-3ozvB: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZUH_A_CAMA422_0 (CAMPHOR 5-MONOOXYGENASE)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	4 / 6	THR B 191 LEU B 252 VAL B 250 VAL B 236	None None None FAD B 405 (-3.6A)	1.09A	2zuhA-3ozvB: undetectable	2zuhA-3ozvB: 23.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IJD_A_C2FA314_0 (UNCHARACTERIZED PROTEIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	5 / 12	THR B 191 LEU B 252 GLY B 180 LEU B 174 ILE B 173	None	1.03A	3ijdA-3ozvB: undetectable	3ijdA-3ozvB: 21.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JB3_A_SAMA1102_0 (STRUCTURAL PROTEIN VP3)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	5 / 12	ILE B 195 PRO B 198 ALA B 199 VAL B 236 ASN B 238	None None None FAD B 405 (-3.6A) None	1.00A	3jb3A-3ozvB: 3.6	3jb3A-3ozvB: 15.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OZU_A_X89A411_1 (FLAVOHEMOPROTEIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	11 / 12	ILE B 25 PHE B 28 TYR B 29 ALA B 56 LEU B 57 VAL B 61 HIS B 85 TRP B 122 ALA B 125 TYR B 126 LEU B 129	ECN B 411 (-4.5A) ECN B 411 (-4.0A) None ECN B 411 (-3.5A) ECN B 411 (-4.1A) DGG B 406 ( 4.8A) HEM B 404 (-3.3A) None DGG B 406 ( 3.8A) HEM B 404 ( 3.9A) HEM B 404 ( 4.3A)	0.31A	3ozuA-3ozvB: 46.1	3ozuA-3ozvB: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OZU_A_X89A411_1 (FLAVOHEMOPROTEIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	11 / 12	PHE B 28 TYR B 29 ALA B 56 LEU B 57 VAL B 61 HIS B 85 LEU B 102 TRP B 122 ALA B 125 TYR B 126 LEU B 129	ECN B 411 (-4.0A) None ECN B 411 (-3.5A) ECN B 411 (-4.1A) DGG B 406 ( 4.8A) HEM B 404 (-3.3A) ECN B 411 (-3.2A) None DGG B 406 ( 3.8A) HEM B 404 ( 3.9A) HEM B 404 ( 4.3A)	0.24A	3ozuA-3ozvB: 46.1	3ozuA-3ozvB: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OZW_A_KKKA413_1 (FLAVOHEMOGLOBIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	4 / 8	ALA B 56 LEU B 57 LEU B 102 PRO B 398	ECN B 411 (-3.5A) ECN B 411 (-4.1A) ECN B 411 (-3.2A) HEM B 404 (-4.4A)	0.73A	3ozwA-3ozvB: 62.3	3ozwA-3ozvB: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OZW_A_KKKA413_1 (FLAVOHEMOGLOBIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	6 / 8	ILE B 25 TYR B 29 GLN B 50 GLN B 53 LEU B 57 LEU B 102	ECN B 411 (-4.5A) None FAD B 405 (-3.1A) HEM B 404 (-3.9A) ECN B 411 (-4.1A) ECN B 411 (-3.2A)	0.65A	3ozwA-3ozvB: 62.3	3ozwA-3ozvB: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OZW_A_KKKA413_1 (FLAVOHEMOGLOBIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	6 / 8	ILE B 25 TYR B 29 GLN B 53 ALA B 56 LEU B 57 LEU B 102	ECN B 411 (-4.5A) None HEM B 404 (-3.9A) ECN B 411 (-3.5A) ECN B 411 (-4.1A) ECN B 411 (-3.2A)	0.49A	3ozwA-3ozvB: 62.3	3ozwA-3ozvB: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OZW_B_KKKB413_1 (FLAVOHEMOGLOBIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	10 / 12	ILE B 25 TYR B 29 HIS B 47 GLN B 52 GLN B 53 ALA B 56 LEU B 57 HIS B 85 LEU B 102 ILE B 371	ECN B 411 (-4.5A) None None None HEM B 404 (-3.9A) ECN B 411 (-3.5A) ECN B 411 (-4.1A) HEM B 404 (-3.3A) ECN B 411 (-3.2A) None	0.74A	3ozwB-3ozvB: 63.6	3ozwB-3ozvB: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OZW_B_KKKB413_1 (FLAVOHEMOGLOBIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	11 / 12	ILE B 25 TYR B 29 HIS B 47 GLN B 53 ALA B 56 LEU B 57 HIS B 85 LEU B 102 ILE B 371 GLY B 397 PRO B 398	ECN B 411 (-4.5A) None None HEM B 404 (-3.9A) ECN B 411 (-3.5A) ECN B 411 (-4.1A) HEM B 404 (-3.3A) ECN B 411 (-3.2A) None FAD B 405 ( 4.4A) HEM B 404 (-4.4A)	0.64A	3ozwB-3ozvB: 63.6	3ozwB-3ozvB: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4G1B_A_ECNA403_1 (FLAVOHEMOGLOBIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	5 / 12	PHE B 28 PHE B 43 GLN B 53 VAL B 98 TYR B 126	ECN B 411 (-4.0A) HEM B 404 ( 3.8A) HEM B 404 (-3.9A) HEM B 404 ( 4.5A) HEM B 404 ( 3.9A)	0.91A	4g1bA-3ozvB: 46.5	4g1bA-3ozvB: 37.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4G1B_A_ECNA403_1 (FLAVOHEMOGLOBIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	6 / 12	PHE B 28 TYR B 29 PHE B 43 VAL B 98 LEU B 102 TYR B 126	ECN B 411 (-4.0A) None HEM B 404 ( 3.8A) HEM B 404 ( 4.5A) ECN B 411 (-3.2A) HEM B 404 ( 3.9A)	0.55A	4g1bA-3ozvB: 46.5	4g1bA-3ozvB: 37.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4G1B_B_ECNB403_1 (FLAVOHEMOGLOBIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	6 / 11	ILE B 24 PHE B 28 TYR B 29 LEU B 57 LEU B 102 TYR B 126	ECN B 411 (-3.5A) ECN B 411 (-4.0A) None ECN B 411 (-4.1A) ECN B 411 (-3.2A) HEM B 404 ( 3.9A)	0.83A	4g1bB-3ozvB: 46.3	4g1bB-3ozvB: 37.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4G1B_B_ECNB403_1 (FLAVOHEMOGLOBIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	5 / 11	ILE B 24 PHE B 28 TYR B 29 LEU B 57 VAL B 61	ECN B 411 (-3.5A) ECN B 411 (-4.0A) None ECN B 411 (-4.1A) DGG B 406 ( 4.8A)	0.93A	4g1bB-3ozvB: 46.3	4g1bB-3ozvB: 37.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4G1B_C_ECNC403_1 (FLAVOHEMOGLOBIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	5 / 9	ILE B 24 PHE B 28 TYR B 29 GLN B 53 VAL B 61	ECN B 411 (-3.5A) ECN B 411 (-4.0A) None HEM B 404 (-3.9A) DGG B 406 ( 4.8A)	1.00A	4g1bC-3ozvB: 45.3	4g1bC-3ozvB: 37.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4G1B_C_ECNC403_1 (FLAVOHEMOGLOBIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	6 / 9	ILE B 24 PHE B 28 TYR B 29 GLN B 53 VAL B 98 LEU B 102	ECN B 411 (-3.5A) ECN B 411 (-4.0A) None HEM B 404 (-3.9A) HEM B 404 ( 4.5A) ECN B 411 (-3.2A)	0.77A	4g1bC-3ozvB: 45.3	4g1bC-3ozvB: 37.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4G1B_C_ECNC403_1 (FLAVOHEMOGLOBIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	5 / 9	ILE B 24 TYR B 29 GLN B 53 LEU B 57 VAL B 61	ECN B 411 (-3.5A) None HEM B 404 (-3.9A) ECN B 411 (-4.1A) DGG B 406 ( 4.8A)	1.21A	4g1bC-3ozvB: 45.3	4g1bC-3ozvB: 37.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4G1B_D_ECND403_1 (FLAVOHEMOGLOBIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	7 / 12	ILE B 24 PHE B 28 TYR B 29 PHE B 43 LEU B 57 LEU B 102 TYR B 126	ECN B 411 (-3.5A) ECN B 411 (-4.0A) None HEM B 404 ( 3.8A) ECN B 411 (-4.1A) ECN B 411 (-3.2A) HEM B 404 ( 3.9A)	0.90A	4g1bD-3ozvB: 46.8	4g1bD-3ozvB: 37.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4G1B_D_ECND403_1 (FLAVOHEMOGLOBIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	6 / 12	ILE B 24 PHE B 28 TYR B 29 PHE B 43 LEU B 57 VAL B 61	ECN B 411 (-3.5A) ECN B 411 (-4.0A) None HEM B 404 ( 3.8A) ECN B 411 (-4.1A) DGG B 406 ( 4.8A)	0.90A	4g1bD-3ozvB: 46.8	4g1bD-3ozvB: 37.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4G1B_D_ECND403_1 (FLAVOHEMOGLOBIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	5 / 12	PHE B 28 PHE B 43 GLN B 53 LEU B 102 TYR B 126	ECN B 411 (-4.0A) HEM B 404 ( 3.8A) HEM B 404 (-3.9A) ECN B 411 (-3.2A) HEM B 404 ( 3.9A)	1.14A	4g1bD-3ozvB: 46.8	4g1bD-3ozvB: 37.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JEC_B_478B401_3 (HIV-1 PROTEASE)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	3 / 3	ASP B 364 LEU B 271 VAL B 351	None	0.62A	4jecB-3ozvB: undetectable	4jecB-3ozvB: 13.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L4B_A_CAMA502_0 (CAMPHOR 5-MONOOXYGENASE)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	4 / 8	THR B 191 LEU B 252 VAL B 250 VAL B 236	None None None FAD B 405 (-3.6A)	1.05A	4l4bA-3ozvB: undetectable	4l4bA-3ozvB: 22.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L4C_B_CAMB502_0 (CAMPHOR 5-MONOOXYGENASE)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	4 / 8	THR B 191 LEU B 252 VAL B 250 VAL B 236	None None None FAD B 405 (-3.6A)	0.92A	4l4cB-3ozvB: undetectable	4l4cB-3ozvB: 22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L4D_A_CAMA503_0 (CAMPHOR 5-MONOOXYGENASE)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	4 / 8	THR B 191 LEU B 252 VAL B 250 VAL B 236	None None None FAD B 405 (-3.6A)	1.03A	4l4dA-3ozvB: undetectable	4l4dA-3ozvB: 22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I1N_G_DVAG9_0 (D-VILLIN HEADPIECE SUBDOMAIN VILLIN-1)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	3 / 3	ALA B 380 ASN B 383 LEU B 384	None	0.38A	5i1nB-3ozvB: undetectable	5i1nB-3ozvB: 13.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I1O_H_DVAH9_0 (D-VILLIN HEADPIECE SUBDOMAIN VILLIN-1)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	3 / 3	ALA B 380 ASN B 383 LEU B 384	None	0.45A	5i1oA-3ozvB: undetectable	5i1oA-3ozvB: 13.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I1P_G_DVAG9_0 (D-VILLIN HEADPIECE SUBDOMAIN VILLIN-1)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	3 / 3	ALA B 380 ASN B 383 LEU B 384	None	0.49A	5i1pD-3ozvB: undetectable	5i1pD-3ozvB: 14.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KOX_A_RFPA502_2 (PENTACHLOROPHENOL 4-MONOOXYGENASE)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	3 / 3	VAL B 90 ARG B 59 PRO B 398	HEM B 404 (-4.0A) None HEM B 404 (-4.4A)	0.74A	5koxA-3ozvB: undetectable	5koxA-3ozvB: 22.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZY_A_CE3A1103_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	4 / 8	TYR B 219 GLN B 189 VAL B 182 GLY B 149	None	0.82A	5nzyA-3ozvB: undetectable	5nzyA-3ozvB: 21.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VLM_D_CVID301_1 (REGULATORY PROTEIN TETR)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	4 / 8	GLN B 52 GLY B 51 ILE B 25 GLN B 30	None None ECN B 411 (-4.5A) None	1.00A	5vlmD-3ozvB: 2.1	5vlmD-3ozvB: 20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VW9_A_NCAA403_0 (FERREDOXIN--NADP REDUCTASE)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	4 / 8	GLY B 277 CYH B 368 GLY B 369 GLU B 394	None None None FAD B 405 (-3.8A)	0.73A	5vw9A-3ozvB: 20.5	5vw9A-3ozvB: 22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X6Y_A_SAMA902_1 (MRNA CAPPING ENZYME P5)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	3 / 3	TYR B 330 ASP B 344 ASP B 342	None	0.67A	5x6yA-3ozvB: 2.1	5x6yA-3ozvB: 18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	5 / 9	ALA B 253 ALA B 86 SER B 87 GLY B 89 SER B 144	None	1.19A	6bklE-3ozvB: undetectable 6bklF-3ozvB: undetectable 6bklG-3ozvB: undetectable 6bklH-3ozvB: undetectable	6bklE-3ozvB: 5.40 6bklF-3ozvB: 5.40 6bklG-3ozvB: 5.40 6bklH-3ozvB: 5.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	6 / 9	SER B 144 ALA B 253 GLY B 153 ALA B 86 SER B 87 GLY B 89	None	1.19A	6bklE-3ozvB: undetectable 6bklF-3ozvB: undetectable 6bklG-3ozvB: undetectable 6bklH-3ozvB: undetectable	6bklE-3ozvB: 5.40 6bklF-3ozvB: 5.40 6bklG-3ozvB: 5.40 6bklH-3ozvB: 5.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FOS_B_PQNB2002_1 (PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A2)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	4 / 6	MET B 1 ALA B 130 LEU B 129 ALA B 125	None HEM B 404 (-4.4A) HEM B 404 ( 4.3A) DGG B 406 ( 3.8A)	1.18A	6fosB-3ozvB: undetectable	6fosB-3ozvB: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6JNH_A_ASCA202_0 (PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	3 / 3	ASN B 238 PRO B 233 GLN B 231	None None FAD B 405 (-3.8A)	0.86A	6jnhA-3ozvB: 4.0	6jnhA-3ozvB: 19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6JOG_A_ASCA202_0 (PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE)	3ozv	FLAVOHEMOGLOBIN (Cupriavidus necator)	3 / 3	ASN B 238 PRO B 233 GLN B 231	None None FAD B 405 (-3.8A)	0.86A	6jogA-3ozvB: 3.9	6jogA-3ozvB: 19.35

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1ERR_B_RALB600_2","ESTROGEN RECEPTOR","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",4,"ASP B 264;MET B 284;LEU B 271;HIS B 392","None","1.22A","1errB-3ozvB:undetectable","1errB-3ozvB:19.02"],["1N2X_B_SAMB402_0","S-ADENOSYL-METHYLTRANSFERASE MRAW","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",5,"GLY B 369;GLY B 274;GLY B 275;GLY B 397;ASN B  80","None;None;None;FAD B 405 ( 4.4A);None","0.81A","1n2xB-3ozvB:6.8","1n2xB-3ozvB:22.33"],["2FXE_A_DR7A102_1","POL PROTEIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",6,"ALA B 309;GLY B 274;GLY B 277;PHE B 373;VAL B 223;ILE B 169","None;None;None;None;FAD B 405 (-3.9A);None","1.24A","2fxeA-3ozvB:undetectable","2fxeA-3ozvB:13.64"],["2QEU_A_ACTA141_0","PUTATIVE CARBOXYMUCONOLACTONE DECARBOXYLASE","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",3,"VAL B 263;ASP B 264;GLU B 186","None","0.61A","2qeuA-3ozvB:2.5","2qeuA-3ozvB:17.05"],["2QEU_C_ACTC141_0","PUTATIVE CARBOXYMUCONOLACTONE DECARBOXYLASE","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",3,"VAL B 263;ASP B 264;GLU B 186","None","0.60A","2qeuC-3ozvB:2.2","2qeuC-3ozvB:17.05"],["2QR2_B_VK3B236_1","PROTEIN (QUINONE REDUCTASE TYPE 2);PROTEIN (QUINONE REDUCTASE TYPE 2)","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",4,"TRP B 151;GLY B 180;GLY B 179;PHE B 157","None","1.04A","2qr2A-3ozvB:undetectable;2qr2B-3ozvB:3.1","2qr2A-3ozvB:22.36;2qr2B-3ozvB:22.36"],["2QXS_A_RALA600_2","ESTROGEN RECEPTOR","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",4,"ASP B 264;MET B 284;LEU B 271;HIS B 392","None","1.26A","2qxsA-3ozvB:undetectable","2qxsA-3ozvB:19.22"],["2QXS_B_RALB600_2","ESTROGEN RECEPTOR","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",4,"ASP B 264;MET B 284;LEU B 271;HIS B 392","None","1.27A","2qxsB-3ozvB:undetectable","2qxsB-3ozvB:19.22"],["2W98_A_P1ZA1351_1","PROSTAGLANDIN REDUCTASE 2","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",5,"TYR B  64;ILE B  68;LEU B 129;VAL B 132;LEU B  78","DGG B 406 ( 4.5A);None;HEM B 404 ( 4.3A);None;None","1.34A","2w98A-3ozvB:undetectable","2w98A-3ozvB:22.84"],["2ZUH_A_CAMA422_0","CAMPHOR 5-MONOOXYGENASE","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",4,"THR B 191;LEU B 252;VAL B 250;VAL B 236","None;None;None;FAD B 405 (-3.6A)","1.09A","2zuhA-3ozvB:undetectable","2zuhA-3ozvB:23.45"],["3IJD_A_C2FA314_0","UNCHARACTERIZED PROTEIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",5,"THR B 191;LEU B 252;GLY B 180;LEU B 174;ILE B 173","None","1.03A","3ijdA-3ozvB:undetectable","3ijdA-3ozvB:21.69"],["3JB3_A_SAMA1102_0","STRUCTURAL PROTEIN VP3","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",5,"ILE B 195;PRO B 198;ALA B 199;VAL B 236;ASN B 238","None;None;None;FAD B 405 (-3.6A);None","1.00A","3jb3A-3ozvB:3.6","3jb3A-3ozvB:15.82"],["3OZU_A_X89A411_1","FLAVOHEMOPROTEIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",11,"ILE B  25;PHE B  28;TYR B  29;ALA B  56;LEU B  57;VAL B  61;HIS B  85;TRP B 122;ALA B 125;TYR B 126;LEU B 129","ECN B 411 (-4.5A);ECN B 411 (-4.0A);None;ECN B 411 (-3.5A);ECN B 411 (-4.1A);DGG B 406 ( 4.8A);HEM B 404 (-3.3A);None;DGG B 406 ( 3.8A);HEM B 404 ( 3.9A);HEM B 404 ( 4.3A)","0.31A","3ozuA-3ozvB:46.1","3ozuA-3ozvB:100.00"],["3OZU_A_X89A411_1","FLAVOHEMOPROTEIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",11,"PHE B  28;TYR B  29;ALA B  56;LEU B  57;VAL B  61;HIS B  85;LEU B 102;TRP B 122;ALA B 125;TYR B 126;LEU B 129","ECN B 411 (-4.0A);None;ECN B 411 (-3.5A);ECN B 411 (-4.1A);DGG B 406 ( 4.8A);HEM B 404 (-3.3A);ECN B 411 (-3.2A);None;DGG B 406 ( 3.8A);HEM B 404 ( 3.9A);HEM B 404 ( 4.3A)","0.24A","3ozuA-3ozvB:46.1","3ozuA-3ozvB:100.00"],["3OZW_A_KKKA413_1","FLAVOHEMOGLOBIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",4,"ALA B  56;LEU B  57;LEU B 102;PRO B 398","ECN B 411 (-3.5A);ECN B 411 (-4.1A);ECN B 411 (-3.2A);HEM B 404 (-4.4A)","0.73A","3ozwA-3ozvB:62.3","3ozwA-3ozvB:100.00"],["3OZW_A_KKKA413_1","FLAVOHEMOGLOBIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",6,"ILE B  25;TYR B  29;GLN B  50;GLN B  53;LEU B  57;LEU B 102","ECN B 411 (-4.5A);None;FAD B 405 (-3.1A);HEM B 404 (-3.9A);ECN B 411 (-4.1A);ECN B 411 (-3.2A)","0.65A","3ozwA-3ozvB:62.3","3ozwA-3ozvB:100.00"],["3OZW_A_KKKA413_1","FLAVOHEMOGLOBIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",6,"ILE B  25;TYR B  29;GLN B  53;ALA B  56;LEU B  57;LEU B 102","ECN B 411 (-4.5A);None;HEM B 404 (-3.9A);ECN B 411 (-3.5A);ECN B 411 (-4.1A);ECN B 411 (-3.2A)","0.49A","3ozwA-3ozvB:62.3","3ozwA-3ozvB:100.00"],["3OZW_B_KKKB413_1","FLAVOHEMOGLOBIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",10,"ILE B  25;TYR B  29;HIS B  47;GLN B  52;GLN B  53;ALA B  56;LEU B  57;HIS B  85;LEU B 102;ILE B 371","ECN B 411 (-4.5A);None;None;None;HEM B 404 (-3.9A);ECN B 411 (-3.5A);ECN B 411 (-4.1A);HEM B 404 (-3.3A);ECN B 411 (-3.2A);None","0.74A","3ozwB-3ozvB:63.6","3ozwB-3ozvB:100.00"],["3OZW_B_KKKB413_1","FLAVOHEMOGLOBIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",11,"ILE B  25;TYR B  29;HIS B  47;GLN B  53;ALA B  56;LEU B  57;HIS B  85;LEU B 102;ILE B 371;GLY B 397;PRO B 398","ECN B 411 (-4.5A);None;None;HEM B 404 (-3.9A);ECN B 411 (-3.5A);ECN B 411 (-4.1A);HEM B 404 (-3.3A);ECN B 411 (-3.2A);None;FAD B 405 ( 4.4A);HEM B 404 (-4.4A)","0.64A","3ozwB-3ozvB:63.6","3ozwB-3ozvB:100.00"],["4G1B_A_ECNA403_1","FLAVOHEMOGLOBIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",5,"PHE B  28;PHE B  43;GLN B  53;VAL B  98;TYR B 126","ECN B 411 (-4.0A);HEM B 404 ( 3.8A);HEM B 404 (-3.9A);HEM B 404 ( 4.5A);HEM B 404 ( 3.9A)","0.91A","4g1bA-3ozvB:46.5","4g1bA-3ozvB:37.95"],["4G1B_A_ECNA403_1","FLAVOHEMOGLOBIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",6,"PHE B  28;TYR B  29;PHE B  43;VAL B  98;LEU B 102;TYR B 126","ECN B 411 (-4.0A);None;HEM B 404 ( 3.8A);HEM B 404 ( 4.5A);ECN B 411 (-3.2A);HEM B 404 ( 3.9A)","0.55A","4g1bA-3ozvB:46.5","4g1bA-3ozvB:37.95"],["4G1B_B_ECNB403_1","FLAVOHEMOGLOBIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",6,"ILE B  24;PHE B  28;TYR B  29;LEU B  57;LEU B 102;TYR B 126","ECN B 411 (-3.5A);ECN B 411 (-4.0A);None;ECN B 411 (-4.1A);ECN B 411 (-3.2A);HEM B 404 ( 3.9A)","0.83A","4g1bB-3ozvB:46.3","4g1bB-3ozvB:37.95"],["4G1B_B_ECNB403_1","FLAVOHEMOGLOBIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",5,"ILE B  24;PHE B  28;TYR B  29;LEU B  57;VAL B  61","ECN B 411 (-3.5A);ECN B 411 (-4.0A);None;ECN B 411 (-4.1A);DGG B 406 ( 4.8A)","0.93A","4g1bB-3ozvB:46.3","4g1bB-3ozvB:37.95"],["4G1B_C_ECNC403_1","FLAVOHEMOGLOBIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",5,"ILE B  24;PHE B  28;TYR B  29;GLN B  53;VAL B  61","ECN B 411 (-3.5A);ECN B 411 (-4.0A);None;HEM B 404 (-3.9A);DGG B 406 ( 4.8A)","1.00A","4g1bC-3ozvB:45.3","4g1bC-3ozvB:37.95"],["4G1B_C_ECNC403_1","FLAVOHEMOGLOBIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",6,"ILE B  24;PHE B  28;TYR B  29;GLN B  53;VAL B  98;LEU B 102","ECN B 411 (-3.5A);ECN B 411 (-4.0A);None;HEM B 404 (-3.9A);HEM B 404 ( 4.5A);ECN B 411 (-3.2A)","0.77A","4g1bC-3ozvB:45.3","4g1bC-3ozvB:37.95"],["4G1B_C_ECNC403_1","FLAVOHEMOGLOBIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",5,"ILE B  24;TYR B  29;GLN B  53;LEU B  57;VAL B  61","ECN B 411 (-3.5A);None;HEM B 404 (-3.9A);ECN B 411 (-4.1A);DGG B 406 ( 4.8A)","1.21A","4g1bC-3ozvB:45.3","4g1bC-3ozvB:37.95"],["4G1B_D_ECND403_1","FLAVOHEMOGLOBIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",7,"ILE B  24;PHE B  28;TYR B  29;PHE B  43;LEU B  57;LEU B 102;TYR B 126","ECN B 411 (-3.5A);ECN B 411 (-4.0A);None;HEM B 404 ( 3.8A);ECN B 411 (-4.1A);ECN B 411 (-3.2A);HEM B 404 ( 3.9A)","0.90A","4g1bD-3ozvB:46.8","4g1bD-3ozvB:37.95"],["4G1B_D_ECND403_1","FLAVOHEMOGLOBIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",6,"ILE B  24;PHE B  28;TYR B  29;PHE B  43;LEU B  57;VAL B  61","ECN B 411 (-3.5A);ECN B 411 (-4.0A);None;HEM B 404 ( 3.8A);ECN B 411 (-4.1A);DGG B 406 ( 4.8A)","0.90A","4g1bD-3ozvB:46.8","4g1bD-3ozvB:37.95"],["4G1B_D_ECND403_1","FLAVOHEMOGLOBIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",5,"PHE B  28;PHE B  43;GLN B  53;LEU B 102;TYR B 126","ECN B 411 (-4.0A);HEM B 404 ( 3.8A);HEM B 404 (-3.9A);ECN B 411 (-3.2A);HEM B 404 ( 3.9A)","1.14A","4g1bD-3ozvB:46.8","4g1bD-3ozvB:37.95"],["4JEC_B_478B401_3","HIV-1 PROTEASE","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",3,"ASP B 364;LEU B 271;VAL B 351","None","0.62A","4jecB-3ozvB:undetectable","4jecB-3ozvB:13.89"],["4L4B_A_CAMA502_0","CAMPHOR 5-MONOOXYGENASE","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",4,"THR B 191;LEU B 252;VAL B 250;VAL B 236","None;None;None;FAD B 405 (-3.6A)","1.05A","4l4bA-3ozvB:undetectable","4l4bA-3ozvB:22.91"],["4L4C_B_CAMB502_0","CAMPHOR 5-MONOOXYGENASE","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",4,"THR B 191;LEU B 252;VAL B 250;VAL B 236","None;None;None;FAD B 405 (-3.6A)","0.92A","4l4cB-3ozvB:undetectable","4l4cB-3ozvB:22.11"],["4L4D_A_CAMA503_0","CAMPHOR 5-MONOOXYGENASE","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",4,"THR B 191;LEU B 252;VAL B 250;VAL B 236","None;None;None;FAD B 405 (-3.6A)","1.03A","4l4dA-3ozvB:undetectable","4l4dA-3ozvB:22.51"],["5I1N_G_DVAG9_0","D-VILLIN HEADPIECE SUBDOMAIN;VILLIN-1","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",3,"ALA B 380;ASN B 383;LEU B 384","None","0.38A","5i1nB-3ozvB:undetectable","5i1nB-3ozvB:13.54"],["5I1O_H_DVAH9_0","D-VILLIN HEADPIECE SUBDOMAIN;VILLIN-1","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",3,"ALA B 380;ASN B 383;LEU B 384","None","0.45A","5i1oA-3ozvB:undetectable","5i1oA-3ozvB:13.54"],["5I1P_G_DVAG9_0","D-VILLIN HEADPIECE SUBDOMAIN;VILLIN-1","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",3,"ALA B 380;ASN B 383;LEU B 384","None","0.49A","5i1pD-3ozvB:undetectable","5i1pD-3ozvB:14.06"],["5KOX_A_RFPA502_2","PENTACHLOROPHENOL 4-MONOOXYGENASE","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",3,"VAL B  90;ARG B  59;PRO B 398","HEM B 404 (-4.0A);None;HEM B 404 (-4.4A)","0.74A","5koxA-3ozvB:undetectable","5koxA-3ozvB:22.63"],["5NZY_A_CE3A1103_1","DNA CROSS-LINK REPAIR 1A PROTEIN","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",4,"TYR B 219;GLN B 189;VAL B 182;GLY B 149","None","0.82A","5nzyA-3ozvB:undetectable","5nzyA-3ozvB:21.66"],["5VLM_D_CVID301_1","REGULATORY PROTEIN TETR","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",4,"GLN B  52;GLY B  51;ILE B  25;GLN B  30","None;None;ECN B 411 (-4.5A);None","1.00A","5vlmD-3ozvB:2.1","5vlmD-3ozvB:20.99"],["5VW9_A_NCAA403_0","FERREDOXIN--NADP REDUCTASE","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",4,"GLY B 277;CYH B 368;GLY B 369;GLU B 394","None;None;None;FAD B 405 (-3.8A)","0.73A","5vw9A-3ozvB:20.5","5vw9A-3ozvB:22.45"],["5X6Y_A_SAMA902_1","MRNA CAPPING ENZYME P5","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",3,"TYR B 330;ASP B 344;ASP B 342","None","0.67A","5x6yA-3ozvB:2.1","5x6yA-3ozvB:18.99"],["6BKL_G_EU7G101_0","MATRIX PROTEIN 2","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",5,"ALA B 253;ALA B  86;SER B  87;GLY B  89;SER B 144","None","1.19A","6bklE-3ozvB:undetectable;6bklF-3ozvB:undetectable;6bklG-3ozvB:undetectable;6bklH-3ozvB:undetectable","6bklE-3ozvB:5.40;6bklF-3ozvB:5.40;6bklG-3ozvB:5.40;6bklH-3ozvB:5.40"],["6BKL_G_EU7G101_0","MATRIX PROTEIN 2","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",6,"SER B 144;ALA B 253;GLY B 153;ALA B  86;SER B  87;GLY B  89","None","1.19A","6bklE-3ozvB:undetectable;6bklF-3ozvB:undetectable;6bklG-3ozvB:undetectable;6bklH-3ozvB:undetectable","6bklE-3ozvB:5.40;6bklF-3ozvB:5.40;6bklG-3ozvB:5.40;6bklH-3ozvB:5.40"],["6FOS_B_PQNB2002_1","PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A2","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",4,"MET B   1;ALA B 130;LEU B 129;ALA B 125","None;HEM B 404 (-4.4A);HEM B 404 ( 4.3A);DGG B 406 ( 3.8A)","1.18A","6fosB-3ozvB:undetectable","6fosB-3ozvB:13.03"],["6JNH_A_ASCA202_0","PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",3,"ASN B 238;PRO B 233;GLN B 231","None;None;FAD B 405 (-3.8A)","0.86A","6jnhA-3ozvB:4.0","6jnhA-3ozvB:19.35"],["6JOG_A_ASCA202_0","PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE","3ozv","FLAVOHEMOGLOBIN","Cupriavidus necator",3,"ASN B 238;PRO B 233;GLN B 231","None;None;FAD B 405 (-3.8A)","0.86A","6jogA-3ozvB:3.9","6jogA-3ozvB:19.35"]]